Learn how Huntsman Cancer Institute uses cutting‑edge diagnostics and personalized care to treat early‑stage prostate cancer. Discover why early detection makes treatment more effective and far less ...

Partners and family members could be the first to notice ...

A recent study reveals a troubling increase in dementia-related deaths among individuals with type 2 diabetes in wealthy nations, despite declines in other mortality rates, highlighting the urgent ...

In people with type 2 diabetes in the world's richest countries, deaths from cardiovascular disease are declining while ...

Having a prostate-specific antigen (PSA) test result above 4.0 ng/mL is considered abnormal and it is worth closer testing, a physician said yesterday, as he suggested individuals with a family ...

Baseline T may provide valuable information about prognosis.

New polling of UK men1 for The Urology Foundation, reveals that while around 80% of UK men have a nickname for their penis, ...

Five-year survival rates are among the lowest of all cancers, at about 25%. But when caught early enough – through annual CT ...

A breakthrough in the fight against pancreatic cancer was unveiled this week, after experts discovered a drug combination that may be able to defeat the disease. The treatment, which involves three ...

Last summer, the Trump administration announced a voluntary pledge by health insurers to reform prior authorization, but patient advocates and medical providers remain skeptical.

A new study led by researchers at The University of Texas MD Anderson Cancer Center found that prostate cancer patients with low testosterone levels may have a higher risk of cancer progressing to a ...

According to the Mayo Clinic, many people with colon cancer don't have symptoms at first.